Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer

Ann Oncol. 2000 Feb;11(2):229-30. doi: 10.1023/a:1008384820279.
No abstract available

MeSH terms

  • Administration, Oral
  • Aged
  • Antibiotics, Antineoplastic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Confidence Intervals
  • Cyclophosphamide / administration & dosage
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Idarubicin / administration & dosage*
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prognosis
  • Remission Induction
  • Survival Rate
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic
  • Cyclophosphamide
  • Idarubicin